• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 157
  • 75
  • 53
  • 12
  • 12
  • 12
  • 9
  • 6
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • Tagged with
  • 360
  • 360
  • 217
  • 105
  • 79
  • 66
  • 59
  • 58
  • 51
  • 49
  • 46
  • 44
  • 43
  • 42
  • 40
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
11

Study of gene promoter methylation in acute promyelocytic leukaemia

Chim, Chor-sang, James. January 2002 (has links)
Thesis (M.D.)--University of Hong Kong, 2002. / Title from title frame. Includes bibliographical references (leaves 186-223).
12

Identified of novel splicing variants of livin in acute myeloid leukemia

Lo, Carfield. January 2009 (has links)
Thesis (M. Phil.)--University of Hong Kong, 2009. / Includes bibliographical references (leaves 99-111) Also available in print.
13

Long-term effects of imatinib on cognition in chronic myeloid leukaemia

Shiell, Kerrie. January 2009 (has links)
Thesis (Ph.D.)--Victoria University (Melbourne, Vic.), 2009.
14

The analysis of human myelogenous leukemia cells in the fluorescence-activated cell sorter

Malcolm, Andrew James January 1983 (has links)
A cell surface protein from human acute myelogenous leukemia (AML) cells has been purified. (Al-Rammahy et al., Cancer Immunol. Immunother. 9:181, 1980; Malcolm et al., J. Immunol. 128:2599, 1982). This material was used to immunize rabbits. The resulting antiserum (anti-AML) showed myelogenous leukemia specificity in that it reacted with myelogenous leukemia cell extracts and did not react with cell extracts of normal individuals or patients with non-myelogenous leukemia or other malignant disorders in the enzyme-linked immunosorbent assay (ELISA). Bone marrow and peripheral blood leucocytes (PBL) from either patients with myelogenous leukemia, other disorders or normal individuals were analysed in the fluorescence-activated cell sorter (FACS IV) after labelling with anti-AML, normal rabbit serum (NRS), or antiserum raised to normal human membrane antigens. Of 40 cell samples from patients with AML, 39 reacted strongly with the anti-AML. Similarly, all of 15 specimens from patients with chronic myelogenous leukemia (CML) reacted with the anti-AML. When 42 bone marrow or PBL samples from patients with a variety of lymphoproliferative disorders were examined, only 2 specimens reacted with the antiserum, both from individuals with diagnoses of acute lymphocytic leukemia (ALL). None of the 14 normal bone marrow or PBL donor specimens tested reacted with the anti-AML. It was also found that essentially all samples from patients in clinical remission from AML had high numbers of cells reactive with the anti-AML. When cells from such individuals were labelled and sorted on the FACS IV, it was found that the cell population fluorescing strongly with the anti-AML contained cells of both myeloid and lymphoid origin. The AML antigen was used to produce AML specific monoclonal antibody. Spleens from AML-antigen immunized Balb/c mice were fused to NS-1 myeloma parental cells and a myelogenous leukemia specific monoclonal antibody was selected from the hybrid colonies produced. This monoclonal antibody (MAL-1) as well as the rabbit anti-AML has been used to identify myelogenous leukemia patient samples in the FACS IV. In addition, this monoclonal also demonstrates positive fluorescence binding to HL-60 (a promyelocytic leukemia cell line), while there is no binding to lymphocytic leukemia cell lines, CCRF-SB-ALL-B and CCRF-CEM-ALL-T. The MAL-1 monoclonal has been shown to be specific for myelogenous leukemia cell extracts in the ELISA and has been successfully used as an immunoadsorbent for the isolation of the AML antigen from cell extracts. No equivalent antigen was found when cell extracts from normal cells, lymphocytic leukemia cells and lymphoma cells were similarly absorbed. These findings indicate that both the rabbit anti-AML serum and MAL-1 monoclonal show specificity for an antigen associated with myelogenous leukemia cells. / Science, Faculty of / Microbiology and Immunology, Department of / Graduate
15

Calpain and Calpastatin in a Mouse Model of Acute Myeloid Leukemia

Farr, Christina 07 December 2011 (has links)
I have studied the calpain system in acute myeloid leukemia using the 32D and 32Dkit cell lines. Specifically, I characterized the calpain system in the cell lines, and performed calpastatin overexpression and knockdown studies. I found that calpain activity is elevated in the 32D and 32Dkit cells, and calpain inhibition causes apoptosis. Both μ- and m-calpain contribute to the calpain activity in these cell lines. The 32Dkit cells have higher calpain activity than the 32D cells, which I have shown is partially attributed to basal ckit activation. Calpastatin was present in both cell lines, but exists mainly in a degraded form. Calpastatin overexpression lowered calpain activity and provided a growth disadvantage to the 32Dkit cells, but had no effect on 32D cells. Calpastatin knockdown caused a significant increase in calpain activity in the 32D cells, which changed the cell cycle distribution but had no other major effects.
16

The expression, regulation and functional role of SOX7 gene in acute myeloid leukemia

Fan, Kin-pong., 范健邦. January 2010 (has links)
published_or_final_version / Medicine / Master / Master of Philosophy
17

Calpain and Calpastatin in a Mouse Model of Acute Myeloid Leukemia

Farr, Christina 07 December 2011 (has links)
I have studied the calpain system in acute myeloid leukemia using the 32D and 32Dkit cell lines. Specifically, I characterized the calpain system in the cell lines, and performed calpastatin overexpression and knockdown studies. I found that calpain activity is elevated in the 32D and 32Dkit cells, and calpain inhibition causes apoptosis. Both μ- and m-calpain contribute to the calpain activity in these cell lines. The 32Dkit cells have higher calpain activity than the 32D cells, which I have shown is partially attributed to basal ckit activation. Calpastatin was present in both cell lines, but exists mainly in a degraded form. Calpastatin overexpression lowered calpain activity and provided a growth disadvantage to the 32Dkit cells, but had no effect on 32D cells. Calpastatin knockdown caused a significant increase in calpain activity in the 32D cells, which changed the cell cycle distribution but had no other major effects.
18

Investigating the functional roles of Mcl-1 in apoptosis in mammalian cells /

Xiao, Kang. January 2009 (has links)
Thesis (Ph.D.)--Hong Kong University of Science and Technology, 2009. / Includes bibliographical references (p. 140-165).
19

Mechanism of Myeloid Differentiation Induced by a Differentiation Factor Isolated from Rat Lung Conditioned Medium

Ansari, Naser A. (Naser Awni) 08 1900 (has links)
A leukemia Differentiation Factor (DF), that induced differentiation of rat leukemia MIA C51 cells, was isolated from endotoxin-stimulated rat lung conditioned media.
20

The role of Sox4 in acute myeloid leukaemia

Putwain, Sarah Lucy January 2014 (has links)
No description available.

Page generated in 0.0499 seconds